About this trial
This study protocol describes a prospective longitudinal observational study designed to evaluate the accuracy of machine learning models in predicting the short-term (24-72 h) risk of reduced participation (training modification or absence due to health complaints, injury, or illness) among elite youth football players (categories U16 to U19).
Full participation in training and matches is a key determinant of athletic development and squad availability in elite youth football. Conventional injury surveillance typically reduces athlete availability to a binary time-loss state and overlooks the continuum on which athletes remain active despite emerging fatigue, minor musculoskeletal complaints, or functional limitations.
In this study, continuous multimodal monitoring integrates external training and match locomotion (Catapult Vector 10 Hz GNSS / 100 Hz IMU), nocturnal autonomic nervous regulation (WHOOP 5.0 wrist-worn photoplethysmography evaluating resting heart rate, heart rate variability RMSSD, and sleep architecture), daily subjective wellness (AMS Hooper Index: sleep quality, stress, fatigue, mood, and muscle soreness), weekly neuromuscular screening (VALD ForceDecks countermovement jumps and NordBord hamstring strength), and anthropometrics with biological maturation offset.
Participation status is adjudicated daily by designated coaching and medical staff. The primary objective is to develop, compare, and internally validate short-term prediction models for the onset transition from full participation to reduced participation, formulated as a single one-step discrete-time hazard read coherently across 24-, 48-, and 72-hour operational horizons. The study aims to evaluate explainable machine learning models (Survival XGBoost, GAMM with SHAP/LIME interpretation) to support training load management and injury risk mitigation within elite academies.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Registered player in the U16 or U19 squad of an elite football academy (SK Sigma Olomouc).
At least three years of structured football training within an organized academy programme.
Regular active participation in microcycle team training and competitive league matches.
Written informed assent by the player and written informed consent by a parent or legal guardian (for minor participants).
Disqualifiers
Pre-existing severe musculoskeletal injury, orthopedic surgery, or neurological disorder preventing full participation at baseline.
Known cardiovascular, metabolic, or systemic disease contraindicating maximal athletic exertion.
Inability or refusal to wear continuous monitoring sensors (Catapult GNSS unit during training, WHOOP strap during sleep).
Prolonged absence from the squad due to non-medical administrative reasons (transfer, academic leave, disciplinary suspension).
Trial population
Elite male youth football players (categories U16 and U19) registered in a licensed national youth football academy (SK Sigma Olomouc, Czechia) competing in top-tier national youth leagues.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Short-Term Incidence of Reduced Participation (24, 48, and 72-Hour Discrete-Time Hazard)
Daily morning consensus assessment (at 8:30 AM) of player participation recorded in the club Athlete Management System (AMS) on a 3-point ordinal scale: Full participation (0), Modified training with \>20% volume reduction or sprint restriction due to medical/health complaints (1), and Complete absence due to injury or illness (2). Levels 1 and 2 are combined into a binary event of reduced participation modeled under a discrete-time survival framework with a 3-day clean washout period (W = 3) for re-entry into the risk set.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.